Risk factor
Good trading liquidity
Profitability factor
Overvalued vs peers
About
SonoScape Medical Corp. is engaged in the global development and production of medical devices, originating from its base in China. Its comprehensive portfolio includes a diverse range of ultrasound diagnostic systems, encompassing cart-based color Doppler, handheld color Doppler, black and white ultrasound units, and specialized veterinary ultrasound apparatus. The company further provides endoscopy solutions, such as sophisticated image processing equipment, illumination tools, and products tailored for gastroenterological examinations. Beyond its hardware offerings, SonoScape extends crucial support services, including expert technical assistance, component provision, educational programs, system upgrades, and direct field intervention. Established in 2002, SonoScape Medical Corp. maintains its corporate headquarters in Shenzhen, China.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, ov
Target Price
The average target price of 300633.SZ is 28.3 and suggests 46.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to